Search

PROCEPT BioRobotics Corp

Chiusa

SettoreSettore sanitario

20.65 0.34

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

20.59

Massimo

20.84

Metriche Chiave

By Trading Economics

Entrata

-27M

-58M

Vendite

11M

94M

EPS

-0.47

Margine di Profitto

-61.905

Dipendenti

888

EBITDA

5.1M

-24M

Raccomandazioni

By TipRanks

Raccomandazioni

Neutrale

Previsioni per 12 mesi

+11.04% upside

Dividendi

By Acuity

Utili prossimi

3 nov 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

171M

1.2B

Apertura precedente

20.31

Chiusura precedente

20.65

Notizie sul Sentiment di mercato

By Acuity

50%

50%

126 / 340 Classifica in Healthcare

PROCEPT BioRobotics Corp Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

28 ago 2026, 19:46 UTC

Procept Biorobotics Corp shares are higher since Thursday's close, despite earlier declines during the session. No specific news was identified for today's movement.

26 ago 2026, 19:26 UTC

News

Procept Biorobotics faces a class action lawsuit alleging securities fraud related to inflated handpiece sales, contributing to a decline in shares during Wednesday's session.

25 ago 2026, 19:46 UTC

Procept Biorobotics shares are higher today amid favorable market conditions, including lower crude oil prices and decreasing Treasury yields. No specific company news was identified.

24 ago 2026, 19:36 UTC

News

Procept Biorobotics faces multiple class action lawsuits alleging securities fraud, contributing to negative sentiment as shares trade lower today.

21 ago 2026, 23:26 UTC

Procept Biorobotics shares are higher in after-market trading, amid a broader market recovery following recent geopolitical tensions and their impact on energy prices.

20 ago 2026, 20:06 UTC

News

Shares of Procept Biorobotics Corp are lower following a class action lawsuit alleging false sales and revenue statements, impacting investor sentiment amid negative earnings reports.

19 ago 2026, 19:26 UTC

News

Procept Biorobotics faces a class action lawsuit from Kaplan Fox & Kilsheimer LLP but shares are trading higher during Wednesday's session.

18 ago 2026, 19:16 UTC

Procept Biorobotics Corp shares are higher, trading near the upper end of their one-month range, despite pulling back from earlier session highs.

17 ago 2026, 19:56 UTC

News

Procept Biorobotics faces downward pressure amid class action lawsuits alleging securities fraud, contributing to negative sentiment and a decline since Friday's close.

14 ago 2026, 19:46 UTC

News

Procept Biorobotics faces class action lawsuits alleging securities fraud, leading shares to decline during Friday's session after earlier reaching a high.

13 ago 2026, 20:06 UTC

Procept Biorobotics Corp is gaining during Thursday's session, following strong momentum and peaking at 7.26% earlier, despite a pullback in recent trading.

12 ago 2026, 20:01 UTC

News

Procept Biorobotics shares are lower amid a class action lawsuit alleging securities fraud related to undisclosed inventory issues and misleading sales practices.

11 ago 2026, 20:02 UTC

Procept Biorobotics Corp shares are higher today, marking the seventh consecutive session of gains. No specific news was identified to explain the increase.

10 ago 2026, 19:53 UTC

Procept Biorobotics Corp shares are higher, supported by reduced Fed rate hike expectations following Friday's weaker jobs report. The stock remains above its 20-day moving average.

7 ago 2026, 20:02 UTC

News

Procept Biorobotics shares are higher as analysts adjust ratings; Wells Fargo sets target at $19.00, while UBS downgrades to "neutral" with a $20.00 target.

6 ago 2026, 20:03 UTC

Procept Biorobotics shares are higher Thursday, recovering from an earlier decline. The stock closed above its 20-day moving average amid broader market dynamics.

5 ago 2026, 19:52 UTC

News

Procept Biorobotics shares are higher as TD Cowen maintains a Buy rating and Piper Sandler reiterates its Overweight rating amid increased investor engagement.

4 ago 2026, 23:02 UTC

News

Procept Biorobotics reported a second-quarter loss of $26.9 million and shares are trading lower in after-market hours following the earnings report.

3 ago 2026, 20:03 UTC

News

Procept Biorobotics shares decline amid a securities class action lawsuit alleging financial misrepresentation through inflated sales and excess inventory.

31 lug 2026, 20:02 UTC

News

Procept Biorobotics shares are rising today, even after UBS downgraded its rating to neutral with a $20 price target.

30 lug 2026, 19:58 UTC

Procept Biorobotics Corp is rising during Thursday's session, driven by a broader market rally and recovery in technology shares. No specific company news was identified.

29 lug 2026, 16:26 UTC

Procept Biorobotics Corp shares are higher Wednesday, recovering from earlier losses amid broader market volatility ahead of the Federal Reserve's interest rate decision.

28 lug 2026, 19:26 UTC

Procept Biorobotics Corp shares are trading higher, reflecting a cumulative gain since Monday, despite negative sentiment from declines in Asian markets.

27 lug 2026, 17:02 UTC

News

Procept Biorobotics reported Q1 revenue of $83.1 million, a 20% increase. Shares are trading higher, recovering from recent declines since Friday's close.

22 lug 2026, 19:41 UTC

Procept Biorobotics Corp shares are lower today, diverging from recent gains. Broader market concerns include rising crude oil prices and inflationary pressures.

21 lug 2026, 16:01 UTC

Procept Biorobotics Corp is declining during Tuesday's session, breaking a trend of higher daily closes. No specific news was identified for the move.

20 lug 2026, 19:56 UTC

Procept Biorobotics Corp shares are higher today, despite earlier volatility and no specific news. Broader market performance remains mixed amid geopolitical tensions.

Confronto tra pari

Modifica del prezzo

PROCEPT BioRobotics Corp Previsione

Obiettivo di Prezzo

By TipRanks

11.04% in crescita

Previsioni per 12 mesi

Media 23.13 USD  11.04%

Alto 29 USD

Basso 19 USD

Basato su 11 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per PROCEPT BioRobotics Corp - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Neutrale

11 ratings

3

Acquista

7

Mantieni

1

Vendi

Sentiment

By Acuity

126 / 340 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Neutral

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo PROCEPT BioRobotics Corp

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
help-icon Live chat